Abstract -Chantitative relationship beween activity and structure of antitumor platinum complexes was studied by C W / 2 method. On the basis of the obtained regression results, some new platinum complexes with methyl substituted aliphatic and cycloaliphatic mines were synthesized and screened, and a new complex [Pt(~PDA)(Cl-Ac),l possessing high activity as cisplatin but with much laver toxicity was found. The interaction of cisplatin with the constituents of DNA was studied by "C IWR and C W / Z method. The reaction mechanism of cisplatin was discussed.
INTRODUCTION
Cisplatin is an effective agent in the treatment of several human cancers. Its clinical effectiveness is limited, however, by dose toxicities such as renal failure, nausea and vomiting. Ever since the early 1970's efforts have been underway to develop additional platinum complexes that would possess higher antitumor activity and lower toxicity, to discover the relationship between activity and structure of the compounds and to elucidate the molecular mechanism of cisplatin. In recent years, antitumor platinum chemistry achieved a rapid development. Some new second generation platinum analogues such as [Pt(isopr),Cl, (OHJ] [PtlNH,),[ 1, l C B C C A ) I and diaminocyclohexane analogues, which have similar activity with cisplatin but lower toxicity than the parent compound, were found and have been put in clinical trials. The relationship between activity and structure of antitumor platinum complexes has become comparatively clear, although extensive quantitative study of the relationship remains to be desired. There is not enough theoretical g r o d to predict and design a new antitumor Pt complex of high activity and low toxicity. With regard to the action mechanism of cisplatin, there is currently considerable evidence that DNA is the principal intracellular target of cisplatin in vivo. The intrastrand cross-linking formed between cisplatin a d DNA through N7,N7 atoms of two neighbouring guanines, the chelation formed through birding of cisplatin with N1,06 atoms of guanine in DNA sequence, and the interstrand cross-linking mechanism have been proposed. The results obtained recently by high frequency 'H study of oligonucleotide-cisplatin adducts and enzymatic digestion studies show that Pt(NH,), unit has a strong preference for chelation to two N, atoms of neighbouring guanines, and induce a distortion of DNA duplex, which might be quite similar to that of a kink or of a bent B DNA, but does not preclude duplex formation with a complementary strand in the case of decamer which has the G-Gdimer situated in the center (refs. 1 , 2 , 3 ) . The action mechanism of cisplatin has not yet been elucidated clearly.
In this paper we s m r i z e recent results obtained in our laboratory including (1) the quantitative relationship between activity and structure of platinum compleites, (2) design, preparation and activity of some new antitumor compounds on the basis of quantitative relationship found and ( 3 ) action mode of cisplatin with DNA.
QUANTITATIVE RELATIONSHIP BETWEEN ACTIVITY AND STRUCTURE OF ANTITUMOR Pt COMPOUNDS
In order to find and design new antitumor platinum compounds with higher activity and laver toxicity, the study of quantitative relationship between activity and structure of platinum compounds is important. Webb (ref. 4) and Dimogro (ref. 5 ) have made some study on this problem, but their conclusions can scarcely be relied upon to predict m r e active c o m p o d s . We have studied by CNIX)/Z-SCF method the electronic structure of about 40 platinum complexes of cis-[PtAm,Cl,], whose activity against ADJ/FC6 in mice of each is well known, and cis-[PtAm,X,l, activity of which against S-180 in mice is also known. Complexes are taken to be squareoplanar, with Pt-Cl bond distance of 2.309 A as in PtC1, and Pt-N bond distance of 2 . 0 5 2 A as in Pt(NH,);+. Substituent coordinates are determined using standard bond parameters from Pople (ref. 6 ). The torsional angle of R-NH, group about its bond with Pt in cis-[PtAm,Cl,] has been optimized. For the bidentate amino ligand, the geometries chosen comprise the knavn bonding characteristics of the moieties involved as closely as possible.
In addition, for [PtAmlX~l complexes with different acidate groups the Pt-X bond distance ard the geometries of acidate groups were selected from crystal structure data of related compounds. Electronic idices such as charges on Pt,X,N atoms, acidate and m i n e mieties, overlap population of PtC1,Pt-N bonds, and PE.AQ for 21 complexes of [PtAm,Cl,] and 23 complexes of [PtAm,X,l were obtained and are shown in Table 1 and 2, and used as independent variables in the following regressions. The variables used are known as lethal dose ( L D B , ) , The significance level for each of the three regressions is m r e than 99%. Here R is the correlation coefficient; S, the standard deviation; and F, the variance ratio. All the regression results are better than those obtained by Webb. Eqns. (11, (2) and (3) indicate that higher the positive charge on Pt atom and the negative charge on chloro atom and lower the overlap population on PtCl bond would result in higher drug activity and therapeutic index, and lower drug toxicity. The eqns. also indicate more hydrogen atoms in amino group, would mean higher activity and therapeutic index of the compound. although higher toxicity.
It is seen in Table 1 The significance level for each of the above two regressions is also m r e than 99%'. Eqn. (4) shows that the toxicity of complexes is dependent mainly on the quantities of QEt-" AE and qg. Eqn. (5) confirms dependence of the inhibition of complexes on q , A E and A . It is noticeable that Q P t -~, Qpt-N and E appear in both the p(TL) and l g ( ! ! / C ) regressions. As decreasing q t -~ and increasing and increasing A E would increase the toxicity a d decrease the activity, so a compound possessing lower toxicity and higher activity against S-180 must have lower QP~-B, higher QP~-N and medium AE values. In addition, higher the charge on N atom, higher would be the activity of the compound. From Table 2 it is clear that 6-9, 18-20 and 23 compounds with malonato and substituted malonato groups have higher charge on N atom, lower QPt-B, higher %t-N and medium E values (ref. 10). All the above results show that regressions with ~(LDsD), p(IDg0) and lg(T1) for cis-[PtAm,Cl,I of different amino groups against ADJ/pC6 and regressions with p(TL) and lg(T/C) for cis-[PtAm,X,] of different acidate and amino groups against S-180 as dependent variables have a high correlation and are highly significant. These findings might therefore be used as basis to predict platinum compourds with higher activity and lower toxicity.
would decrease the toxicity and increase the activity, 2.3-dimethyl-2.3-butanediamine (IMBA) and 1,2,2'-trimthyl-l,3 -~yclopentane-diamine ( X P D A ) were synthesized and corresponding complexes with unsubstituted aliphatic and cycloaliphatic amine like 1,3-~yclopentanediamine (CPDA), 1,3-cyclohexanediamine (CHDA) and amantadine (AMT) were also synthesized for comparison (refs. 11-14) . All compounds obtained were characterized by elemental analysis, infrared spectroscopic, thermogravimetric and differential thermal analysis. The animal tests were performd by Prof. Ji in Institute of Materia M i c a , Chinese Academy of Medical Science. The activity of platinum compounds containing IMBA, TXPDA and CPDA against L-1210 in DBA/2 mice is shown in Table 3 (refs. 11, 12) . Data in Table 3 
DESIGNING, SYNTHESIS AND ACTIVITY OF SOME ANTITUMOR

MODE OF ACTION OF CISPLATIN WITH DNA
In order to elucidate the antitumor action mechanism of cisplatin, we have undertaken studies on the interaction of cisplatin with the constituents of DNA by I3C M ard CNDo/2 method. The chemical shifts of proton-decoupled "C IWR spectra of interaction systems are shown in NH,),(N,,N1 -GuoH-~)l~t.nNO, was further verified by its isolation and identification from I:1 mole ratio reaction system of cis-[Pt(NH3)2(H20)212t a d guanosine at pH = 7. It is known that for a long time the isolation of Pt-guanosine complex in 1:l has been attempted, but no success achieved. We have tried to separate it by G-10,G-25 chromatography but also failed to get the pure compourd. By I3C IWR spectral analysis, we have fourd the main impurity in the product obtained is [Pt (NH,) (N,-Guo) In order to estimate the bording character of different coordinated species ard the influence of platinum birding to different sites of guanine upon the electronic charge distribution in guanine melecule, the electronic structures of guanine ard 3 &el compourds of platinum differently coordinated with guanine has been stdied by C W / Z method (Fig. 2 ) . Structure I is guanine; * charge on C6,Ca of guanine, whose N bound with Pt.
** charge on C6,C2 of guanine, whose N bourd with Pt.
A part of the results obtained by CNL33/2 calculation of model compourds of cisplatin a d guanine are given in Table 5 All above results imply that the binding of platinum to N7 atom of neighboring guanines on the same strand of CNA only weakens the hydrogen bonds between G C base pair, but does not rupture them. Hawever when platinum is bonded to neighbouring guanine on the same strad of DNA through NT,N1 formation of hydrogen bonds and consequently of G C base pair is all prevented. Therefore the intrastrand cross-linkage formed between cisplatin and DNA through N,," atoms of two adjacent guanines is a possible mechanism of preventing replication of DNA by cisplatin. However the formation of intrastrand cross-linkage of two adjacent guanines through N,,N, by cisplatin has not yet been found in the 'H IWR study of oligonucleotidecisplatin adducts and their enzymatic digestion studies. Possible reasons may be the m l e ratio of cisplatin to oligonucleotide in the reaction systems is too low, and the rate of N,,Nl cross-linkage is comparatively lower than that of NT,N7 cross-linkage. The 'H and I3C MR studies of the boding of cisplatin with oligonucleotides in higher mole ratio are under way.
